West Pharmaceutical Services (WST) Current Taxes (2009 - 2026)

West Pharmaceutical Services has disclosed Current Taxes across 18 years of filings, most recently posting $78.9 million for Q1 2026.

• Current Taxes for Q1 2026 came in at $78.9 million, up 253.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $78.9 million (up 253.81% YoY), and the FY2025 annual result was $28.1 million, down 10.79% from the prior year.
• Current Taxes came in at $78.9 million for Q1 2026 at West Pharmaceutical Services, up from $28.1 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $78.9 million in Q1 2026 to a low of $15.0 million in Q3 2023.
• The 5-year median for Current Taxes is $28.5 million (2025), against an average of $31.1 million.
• Across the five-year window, Current Taxes tumbled 71.53% in 2024 and soared 253.81% in 2026, its largest moves.
• West Pharmaceutical Services' Current Taxes stood at $24.8 million in 2022, then tumbled by 33.06% to $16.6 million in 2023, then surged by 89.76% to $31.5 million in 2024, then slipped by 10.79% to $28.1 million in 2025, then soared by 180.78% to $78.9 million in 2026.
• The last three Current Taxes figures came in at $78.9 million (Q1 2026), $28.1 million (Q4 2025), and $33.3 million (Q3 2025), per Business Quant data.